Team Science (The Liver Health Study)

Liver damage from alcohol intake and weight-related behaviors is preventable and treatable only through lifestyle changes. This mixed-methods randomized controlled trial compares standard and enhanced approaches to screening, brief intervention, and referral to treatment/prevention (SBIRT/P) to identify and intervene for metabolism- and alcohol-associated liver disease (MetALD). Our multidisciplinary team aims to show that integrating results of noninvasive liver screening with Fibroscan®, a painless ultrasound that measures stiffness and fat in the liver, can optimize our brief intervention. The study population is adults age 21+ who speak Spanish or English from underresourced communities with alcohol- and weight-related risks for MetALD.

NCT Number	NCT06924281
Lead Sponsor	Brown University Collaborators: National Institute of General Medical Sciences (NIGMS)
Conditions	Steatotic Liver Disease of Mixed Origin (MetALD)
Enrollment	14 participants
Start Date	2025-04-25
Primary Completion	2025-08-29 (estimated)
Study Completion	2025-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-04